Daiichi Sankyo Chairman Shoda Relinquishes Job To Be Senior Adviser
This article was originally published in PharmAsia News
Executive Summary
Takashi Shoda, chairman of Daiichi Sankyo when it acquired Ranbaxy Laboratories six years ago, is relinquishing the position and becoming senior corporate adviser.